LAX.SH
PRIVI SPECIALITY CHE LTD·CHEMICALS 57.95·Chemicals & Petrochemicals Companies
Price
3,330.6
+1.16%52W Range
Market Cap
₹13,010.22 Cr
Traded: ₹26.98 Cr (0.21%) 0.0x
Free Float: ₹2,724.34 Cr (0.99% of FF traded)
Volume · 60D trend
80.9 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
RS Score
Create a free account to unlock your edge
Scanners, market pulse, FII/DII data, and TradingView charts — free forever
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +15.0% | +17.0% | -- | +22.0% | Accelerating |
| ROE | +15.0% | +15.0% | +19.0% | -- | -- | Stable |
| Return | +28.0% | +17.0% | +48.0% | +38.0% | -- | Stable |
| Profit | -- | +27.0% | +144.0% | -- | +61.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 666 | 722 | 605 | 679 | 559 | 614 | 491 | 533 | 464 | 484 | 404 | 455 | 409 | 399 | 420 | 400 |
| Expenses | 514 | 541 | 453 | 497 | 427 | 481 | 378 | 423 | 370 | 393 | 314 | 366 | 354 | 367 | 368 | 357 |
| Operating Profit | 152 | 180 | 151 | 182 | 132 | 133 | 113 | 110 | 94 | 91 | 90 | 89 | 55 | 32 | 52 | 43 |
| Other Income | 15 | 4 | 7 | 0 | 9 | 15 | 2 | 4 | 3 | 8 | 6 | 7 | 6 | 3 | 6 | 9 |
| Interest | 17 | 18 | 19 | 21 | 24 | 23 | 22 | 22 | 22 | 25 | 24 | 25 | 24 | 23 | 20 | 15 |
| Depreciation | 37 | 36 | 36 | 36 | 36 | 35 | 32 | 32 | 32 | 30 | 32 | 31 | 31 | 31 | 30 | 26 |
| Profit Before Tax | 113 | 130 | 104 | 125 | 81 | 90 | 61 | 61 | 43 | 44 | 39 | 40 | 6 | -19 | 8 | 11 |
| Tax % | 27.0% | 27.0% | 28.0% | 28.0% | 29.0% | 29.0% | 27.0% | 26.0% | 27.0% | 28.0% | 26.0% | 25.0% | 30.0% | -21.0% | 31.0% | 30.0% |
| Net Profit | 83 | 94 | 75 | 90 | 58 | 64 | 44 | 45 | 31 | 32 | 29 | 30 | 5 | -15 | 6 | 8 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 21.5 | 24.0 | 19.9 | 24.0 | 15.8 | 17.0 | 11.4 | 11.4 | 8.0 | 7.9 | 7.4 | 7.8 | 1.2 | -3.5 | 1.4 | 2.0 |
| Sales Growth (YoY) | 19.1% | 17.6% | 23.2% | 27.4% | 20.5% | 26.9% | 21.5% | 17.1% | 13.4% | 21.3% | -3.8% | 13.8% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -7.8% | 19.3% | -10.9% | 21.5% | -9.0% | 25.1% | -7.9% | 14.9% | -4.1% | 19.8% | -11.2% | 11.3% | 2.5% | -5.0% | 5.0% | -- |
| OP Growth (YoY) | 15.2% | 35.3% | 33.6% | 65.5% | 40.4% | 46.2% | 25.6% | 23.6% | 70.9% | 184.4% | 73.1% | 107.0% | -- | -- | -- | -- |
| OP Growth (QoQ) | -15.6% | 19.2% | -17.0% | 37.9% | -0.8% | 17.7% | 2.7% | 17.0% | 3.3% | 1.1% | 1.1% | 61.8% | 71.9% | -38.5% | 20.9% | -- |
| Profit Growth (YoY) | -- | 41.0% | 76.0% | 110.0% | 97.0% | 114.0% | 55.0% | 46.0% | 579.0% | 327.0% | 410.0% | 286.0% | -79.0% | -165.0% | -79.0% | -53.0% |
| EPS Growth (YoY) | 36.0% | 40.9% | 75.5% | 110.3% | 97.5% | 114.5% | 54.5% | 46.4% | 579.7% | 326.6% | 411.1% | 286.1% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -10.1% | 20.1% | -16.9% | 51.6% | -6.9% | 49.6% | -0.4% | 42.4% | 1.1% | 7.7% | -5.6% | 561.0% | 133.7% | -343.1% | -28.7% | -- |
| OP Margin | 22.8% | 24.9% | 25.0% | 26.8% | 23.6% | 21.7% | 23.0% | 20.6% | 20.3% | 18.8% | 22.3% | 19.6% | 13.4% | 8.0% | 12.4% | 10.8% |
| Net Margin | 12.5% | 13.0% | 12.4% | 13.3% | 10.4% | 10.4% | 9.0% | 8.4% | 6.7% | 6.6% | 7.2% | 6.6% | 1.2% | -3.8% | 1.4% | 2.0% |
| Material Cost % | 56.0% | 56.0% | 50.0% | 49.0% | 49.0% | 56.0% | 49.0% | 55.0% | 56.0% | 57.0% | 53.0% | 59.0% | 62.0% | 61.0% | 60.8% | 58.7% |
| Employee Cost % | 4.0% | 3.0% | 5.0% | 4.0% | 5.0% | 4.0% | 4.0% | 4.0% | 4.0% | 4.0% | 5.0% | 4.0% | 4.0% | 5.0% | 4.3% | 5.1% |
| P/S | 4.87 | 5.65 | 5.55 | 5.07 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 37.23 | 44.26 | 45.40 | 44.54 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 9.21 | 10.26 | 10.99 | 9.58 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Intimation of Board ....
Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026.
Notice of Hon''ble NCLT Convened Shareholders Meeting in the matter of Scheme of Amalgamation, Scheduled to be held on Tuesday, October 27, 2026 At 12:30 p.m.
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Intimation of Schedule of Analyst / Institutional Investor Meeting to be held on August 18,2026.
Scrutinizer''s Report on the voting results of the business transacted at the 41st Annual General Meeting (AGM)
Summary of the Proceedings of 41st (Forty First) Annual General Meeting of the Company held on Friday August 07,2026.
Unaudited Financial Results for the Quarter ended June 30,2026.
Announcement under Regulation 30 (LODR) - Analyst / Investor Meet- Intimation of Q1 Earnings call.
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve Intimation of Board ....
A Letter containing the exact web-link and path for accessing Annual report for FY 2025-26.
Newspaper publication giving intimation about 41st AGM scheduled to be held on August 07, 2026.
Business Responisbility and Sustainability Report for the FY 2025-26.
Annual Report for the year 2025-26 of the Company.
41st Annual General Meeting (AGM) of the Company to be held on Friday, August 07,2026 at 04:00 PM.
Newspaper Publication regarding 41st AGM.
Certificate under Regulation 74(5) of SEBI (Depository & Participants) Regulations,2018
Intimation of Credit ratings under SEBI (LODR), Regulations 2015
Intimation of Credit ratings under SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Intimation of Closure of Trading Window for the first quarter ending June 30,2026
Intimation of Analyst / Investor''s Plant Visit (Mahad Facility) on June 19, 2026
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015.
Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Transcript of Analyst/Investor Meet held on Tuesday May12,2026
Annual Secretarial Compliance Report 2025-26
Audio Recording of Analyst/ Investors Meet held on Tuesday, May 12,2026.
Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31,2026.
Board approves Dividend
Corporate Action- Record date is July 31, 2026 for Final Dividend.
Outcome of the Board Meeting for Re-appointment of Internal and Cost Auditor.
Outcome of the Board Meeting for re-appointment of Executive ( Whole-time Director) of the Company.
Investor Presentation - Financial and operational Review for the quarter and year ended March 31,2026.
Outcome of Board Meeting held today i.e. Monday, May 11, 2026
Intimation regarding receipt of observation letter from BSE Limited dated May 06,2026 in relation to the scheme of Arrangement.
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 regrading receipt of No Objection Letter received from National Stock Exchange of India Limited in relation to scheme of Amalgamation.
Announcement under Regulation 30 (LODR)- Analyst/ Investor Meet- Intimation
Announcement under Regulation 30 (LODR)- Analyst/ Investor Meet- Intimation
Privi Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve Intimation of Board ....
Intimation of reaffirmation of ratings under SEBI (LODR) Regulations, 2015
Certificate Under Reg 74(5) of SEBI (DP) Regulations, 2018.
Subscription towards equity share capital in joint venture company, Prigiv Specialties Private Limited
Intimation Schedule of Analyst/Investors Virtual Meeting Scheduled to be held on March 31, 2026 @ 03:30 pm onwards.
Intimation of Closure of trading window for the quarter and year ended March 31, 2026.
Announcement under Reg 30(LODR) - Update on Acquisition of 5.80% of Equity Share Capital as investment in Solar Power Project pursuant to definitive agreement entered into with Radiance ....
Cancellation of Investor Meet scheduled to be held on February 18,2026.
Transcript of Analyst/ Investor Meet held on Tuesday, February 10,2025
Intimation of Schedule of Analyst/ Institutional Investoe Meeting under SEBI (LODR) Regulations,2015
Intimation of Schedule of Analyst/ Institutional Investor meeting under SEBI (LODR), Regulation 2015
Audio Recording Analyst/ Investors Meet held on Tuesday, February 10,2026.
Investor Prsentation for the Quarter and Nine Month ended December 31,2025.
Annual Reports
16Credit Ratings
6Concalls
20Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Oct 2024
31 Oct 2024Aug 2024
31 Aug 2024Jul 2024
31 Jul 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Aug 2023
31 Aug 2023Jun 2023
30 Jun 2023Feb 2023
28 Feb 2023May 2022
31 May 2022Jan 2022
31 Jan 2022Jul 2017
31 Jul 2017Jul 2016
31 Jul 2016Nov 2011
30 Nov 2011Held by ETFs
9 ETFs hold PRIVISCL · sorted by weight
Held by Mutual Funds
7 schemes hold PRIVISCL · sorted by weight